VV5 Stock Chart & Stats
€0.17
<€0.01(2.19%)
At close: 4:00 PM EDT
€0.17
<€0.01(2.19%)
Day’s Range― - ―
52-Week Range€0.06 - €0.21
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€37.21M
Enterprise Value€97.20M
Total Cash (Recent Filing)€4.53M
Total Debt (Recent Filing)€33.71M
Price to Earnings (P/E)―
Beta-0.36
Next Earnings
Dec 01, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding185,816,350
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)0.83
Price to Sales (P/S)0.88
P/FCF Ratio5.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€44.15M
Bulls Say, Bears Say
Bulls Say
Margin And EBITDA ImprovementThe sharp improvement in gross margin and adjusted EBITDA indicates stronger operating execution and better economics across the business. If sustained, higher margins can improve internal funding capacity, support debt reduction, and provide resilience as the company reallocates resources toward growth markets.
Ohio Growth PlatformOhio is emerging as a scalable growth platform, combining expanding sales with a larger company-operated retail footprint. Continued dispensary openings and improving inventory availability could strengthen Vext’s local market position and increase the contribution from vertically integrated operations.
Cash Generation And Balance-sheet ProgressPositive operating and free cash flow show that Vext can generate cash despite reported losses, while improved working capital and refinancing actions provide additional financial support. This gives management more capacity to fund Ohio expansion and gradually address debt obligations.
Bears Say
Persistent Losses And Revenue PressureThe company has not yet restored consistent bottom-line profitability, and declining revenue increases the challenge of absorbing fixed operating costs. Continued losses can limit reinvestment, slow debt reduction, and make margin improvements less durable if sales do not stabilize.
Arizona Market And Cultivation WeaknessArizona demonstrates the structural pressure facing part of Vext’s operating footprint, where weak demand and depressed wholesale prices made cultivation uneconomic. Exiting production may improve capital efficiency, but it also reduces near-term revenue and leaves the company reliant on successful repositioning.
Large Uncertain Tax LiabilityThe enlarged current tax position represents a material claim on liquidity relative to the company’s scale and cash balance. Until regulatory changes or other relief reduce the obligation, it can constrain capital allocation, complicate balance-sheet repair, and increase financial uncertainty.
Vext Science News
VV5 FAQ
What was Vext Science’s price range in the past 12 months?
Vext Science lowest stock price was €0.06 and its highest was €0.21 in the past 12 months.
What is Vext Science’s market cap?
Vext Science’s market cap is €37.21M.
When is Vext Science’s upcoming earnings report date?
Vext Science’s upcoming earnings report date is Dec 01, 2026 which is in 34 days.
How were Vext Science’s earnings last quarter?
Vext Science released its earnings results on Aug 20, 2026. The company reported €0 earnings per share for the quarter.
Is Vext Science overvalued?
According to Wall Street analysts Vext Science’s price is currently Overvalued.
Does Vext Science pay dividends?
Vext Science does not currently pay dividends.
What is Vext Science’s EPS estimate?
Vext Science’s EPS estimate is 0.
How many shares outstanding does Vext Science have?
Vext Science has 185,816,350 shares outstanding.
What happened to Vext Science’s price movement after its last earnings report?
Vext Science reported an EPS of €0 in its last earnings report. Following the earnings report the stock price went up 2.439%.
Which hedge fund is a major shareholder of Vext Science?
Currently, no hedge funds are holding shares in DE:VV5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vext Science
Vext Science, Inc., through its various subsidiaries, operates as a comprehensive agricultural technology, services, and property management company within the United States cannabis sector. Its operations span the entire product lifecycle, from cultivating and extracting to manufacturing and distributing THC and CBD vape cartridges, concentrates, and edibles. The company also manages retail dispensaries and conducts wholesale distribution of cannabis-derived THC and hemp-derived CBD products, marketed under its Vapen and Pure Touch Botanicals brands. Expanding its edible range, Vext Science offers various THC-infused items under the Vapen Kitchens brand, including Vapen Clear products, chocolate bars, syrups, snacks, candies, and gummies. Incorporated in 2015, the company was formerly known as Vapen MJ Ventures Corporation, adopting its current name, Vext Science, Inc., in November 2019. Its headquarters are located in Phoenix, Arizona.
VV5 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized meaningful operational and margin improvements driven by Ohio execution and higher cultivation yields, alongside successful financing and balance sheet progress. These positives were balanced against a lower top line (driven by a planned Arizona cultivation wind-down), ongoing market weakness in Arizona, a significant uncertain tax liability, and modest reported operating cash flow due to deliberate inventory and payable timing. Management communicated a clear strategy to redeploy capital from Arizona to Ohio and to pay down debt, and they reported concrete near-term actions and improving trends.View all DE:VV5 earnings summariesTechnical Analysis
Leef Brands
―
Charlotte's Web Holdings
―
MediPharm Labs
―
Planet 13 Holdings
―
Avicanna
―